IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 153 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $243,005,943 | -11.5% | 25,234,262 | -2.2% | 0.01% | -12.5% |
Q2 2023 | $274,560,679 | +3.1% | 25,804,575 | +1.9% | 0.01% | 0.0% |
Q1 2023 | $266,344,413 | -16.6% | 25,317,910 | -1.8% | 0.01% | -20.0% |
Q4 2022 | $319,332,192 | +23.4% | 25,773,381 | +3.2% | 0.01% | +11.1% |
Q3 2022 | $258,688,000 | -16.6% | 24,970,098 | -7.1% | 0.01% | -10.0% |
Q2 2022 | $310,044,000 | +69.5% | 26,890,220 | +85.0% | 0.01% | +100.0% |
Q1 2022 | $182,873,000 | +9.2% | 14,536,759 | +1.2% | 0.01% | +25.0% |
Q4 2021 | $167,541,000 | +2.9% | 14,368,890 | +15.2% | 0.00% | -20.0% |
Q3 2021 | $162,883,000 | +9.6% | 12,471,775 | +8.0% | 0.01% | +25.0% |
Q2 2021 | $148,662,000 | -0.4% | 11,550,907 | -13.5% | 0.00% | 0.0% |
Q1 2021 | $149,239,000 | +0.4% | 13,348,564 | +2.3% | 0.00% | -20.0% |
Q4 2020 | $148,580,000 | +17.2% | 13,044,650 | -7.4% | 0.01% | 0.0% |
Q3 2020 | $126,733,000 | -15.1% | 14,089,184 | -2.6% | 0.01% | -16.7% |
Q2 2020 | $149,313,000 | +10.9% | 14,468,180 | +8.5% | 0.01% | -14.3% |
Q1 2020 | $134,601,000 | -25.3% | 13,340,266 | -1.5% | 0.01% | 0.0% |
Q4 2019 | $180,237,000 | +56.0% | 13,541,545 | +0.6% | 0.01% | +40.0% |
Q3 2019 | $115,516,000 | -17.1% | 13,455,583 | +5.7% | 0.01% | -16.7% |
Q2 2019 | $139,270,000 | -14.4% | 12,730,319 | +5.8% | 0.01% | -14.3% |
Q1 2019 | $162,768,000 | +27.6% | 12,030,163 | -2.3% | 0.01% | +16.7% |
Q4 2018 | $127,610,000 | -43.3% | 12,317,565 | +1.0% | 0.01% | -40.0% |
Q3 2018 | $225,188,000 | -0.2% | 12,198,644 | +3.3% | 0.01% | 0.0% |
Q2 2018 | $225,728,000 | +30.2% | 11,805,955 | +5.0% | 0.01% | +25.0% |
Q1 2018 | $173,408,000 | -1.1% | 11,238,427 | -4.0% | 0.01% | 0.0% |
Q4 2017 | $175,414,000 | -6.3% | 11,702,048 | -1.4% | 0.01% | -11.1% |
Q3 2017 | $187,237,000 | -14.2% | 11,872,904 | +2.7% | 0.01% | -25.0% |
Q2 2017 | $218,310,000 | +12.6% | 11,562,975 | +1.7% | 0.01% | +9.1% |
Q1 2017 | $193,944,000 | +43385.2% | 11,368,314 | +38835.2% | 0.01% | +1000.0% |
Q4 2016 | $446,000 | +51.7% | 29,198 | +57.6% | 0.00% | – |
Q3 2016 | $294,000 | +57.2% | 18,525 | +29.5% | 0.00% | – |
Q2 2016 | $187,000 | +92.8% | 14,309 | +60.8% | 0.00% | – |
Q1 2016 | $97,000 | +34.7% | 8,898 | +42.4% | 0.00% | – |
Q4 2015 | $72,000 | +100.0% | 6,248 | +81.6% | 0.00% | – |
Q3 2015 | $36,000 | -12.2% | 3,440 | 0.0% | 0.00% | – |
Q2 2015 | $41,000 | -29.3% | 3,440 | -5.6% | 0.00% | – |
Q1 2015 | $58,000 | +3.6% | 3,643 | 0.0% | 0.00% | – |
Q4 2014 | $56,000 | +19.1% | 3,643 | 0.0% | 0.00% | – |
Q3 2014 | $47,000 | -16.1% | 3,643 | 0.0% | 0.00% | – |
Q2 2014 | $56,000 | +30.2% | 3,643 | +2.7% | 0.00% | – |
Q1 2014 | $43,000 | -87.3% | 3,548 | -87.9% | 0.00% | -100.0% |
Q4 2013 | $339,000 | -2.0% | 29,212 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $346,000 | +19.3% | 29,212 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $290,000 | – | 29,212 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
EMC Capital Management | 43,315 | $417 | 0.31% |